Viatris Inc. announced that Abevmy® is now available in Canada. Abevmy, is a biosimilar to Roche’s Avastin® (bevacizumab) and has been authorized for use by Health Canada across four oncology indications.
The clinical oncology pharmacist is part of a multidisciplinary team consisting of physicians, pharmacists, pharmacy technicians, nurses, social workers and dieticians from BC Cancer and Northern Health.
We are very pleased to announce that applications for the 2nd annual HOPE (Honouring Oncology Pharmacy Excellence) Awards in Pharmacy are now open! The HOPE Awards honour and recognize accomplishments of oncology pharmacists across Canada.